MCL1 and T-cell large granular lymphocyte leukemia: In cells derived from patients with T-LGL, treatment with a JAK kinase inhibitor led to decreased myeloid cell leukemia 1 (Mcl-1) protein expression and increased apoptosis in the majority of samples.